Tender detail
Non-exclusive rebate agreement for budesonide medicines
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing the active substance budesonide for the period 01/08/2026 to 31/07/2028. Bidders should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible, and the exact requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.